NexImmune partners with Zephyr AI to discover novel targets for T-cell-mediated therapies for cancer March 18, 2022 No Comments
WTX-124, a conditionally activated IL-2 prodrug with minimized toxicity in cancer models March 18, 2022 No Comments
Sanofi and Seagen to develop and commercialize antibody-drug conjugates for cancer targets March 17, 2022 No Comments
CD19/CD22 targeting bivalent CAR-T therapy show efficacy in leukemia models March 16, 2022 No Comments
SIWA-318H shows efficacy in immune-competent humanized mouse xenograft model for pancreatic cancer March 15, 2022 No Comments
NexImmune enters melanoma research and evaluation collaboration with NYU Langone center March 15, 2022 No Comments
RSS